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Abstract 
Enterococci are reservoirs for transmission of the most clinically important antimicrobial 
resistances such as vancomycin resistance. Therefore, this work aimed to determine the 
occurrence of enterococci and their respective vancomycine resistance genes (vanA and vanB) 
from different sources. Two hundred and twenty-four samples from chickens, turkey, fish and 
human urine, as well as, two types of human food including milk (raw and milk from mastitic 
animals) and sausage were tested for isolation of Enterococcus species. The isolates were 
identified morphologically and biochemically using catalase test, sodium chloride tolerance and 
growth at pH 9.6 and 10- 45˚C. The vancomycin resistance profile of the isolates was verified by 
both disc diffusion and agar dilution methods. The genotypic enterococcal identification at both 
genus and species levels and their vancomycine resistance genes were also ascertained using 
PCR amplification of the respective genes for 28 isolates. Enterococci isolation rate was 70% of 
the examined samples with a higher percentage of vancomycine resistance (53.5%) and the 
minimum inhibitory concentrations (MICs) ranged from 16 to 512 µg/mL. Molecular 
identification of 28 enterococcal isolates revealed the dominance of E. faecalis (42.8%) and 
clarified a higher proportion of vanA (78.5%) and vanB (67.8%) genes. In conclusion, 
administration of the antimicrobials mainly vancomycin may be considered as a pronounced 
stress factor in the veterinary and human practices. In addition, VRE can act as a reservoir for 
vancomycin resistance. 
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Introduction 
Enterococci are Gram- positive cocci that 
present in different sources such as soil, food, 
water and a wide variety of living animals 
because of their ability to grow and survive 
under harsh conditions. Their major habitat is 
the gastrointestinal tract (GIT) of humans and 
other animals where they make up a 
significant portion of the normal gut flora [1]. 
Some strains are also important opportunistic 
pathogens responsible for serious human 
diseases and nosocomial infections [2,3]. 
Enterococci in food might survive intestinal 
passage and the frequent isolation of antibiotic 
resistant Enterococci from fermented food 
products implies a risk for the transmission of 
resistance genes to the human gut microbiota 
[4]. Such transmission might result in an 
increase of the prevalence and lateral transfer 
of antibiotic resistance genes, thereby 
constituting an impairment of human health. 
Unfortunately, bacteria became rapidly 
resistant to several classes of clinically 
relevant antibiotics, hampering effective 
treatment [5] However, the uncontrolled use of 
antibiotics in therapeutics and as growth 
promoters in animal husbandry has led to 
increasing the prevalence of antibiotic resistant 
bacteria worldwide [6,7]. Spontaneous 
mutations and the acquisition of antibiotic 
resistance genes by horizontal gene transfer 
(HGT) contribute further to the spread of 
antibiotic resistant bacteria [8]. Particularly in 
the hospital environment, the use of antibiotics 
leads to the selection of resistant organisms, 
resulting in difficulties in the treatment of 
nosocomial infections [3,9]. The most 
worrisome resistance trait to emerge in 
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enterococci is the resistance to vancomycin 
since the first report of vancomycin resistant 
enterococci (VRE) in France which was shown 
to be plasmid mediated and transferable [10].  
The most common phenotype of vanA 
resistance is associated with acquired, 
inducible, high-level resistance to both 
vancomycin (MIC>32 mg/L) and teicoplanin 
(MIC>16 mg/L), and is carried on transposon 
(Tn1546) that is transferable to other 
susceptible enterococci by conjugation. 
Several acquired glycopeptide resistant 
phenotypes have been characterized since 
then, including vanB and less common vanD, 
vanE and vanG types. The vanB phenotype, 
which is chromosomally mediated, inducible 
and transferable by conjugation, facilitated 
inducible resistance to vancomycin but not to 
teicoplanin [11]. Vancomycin resistant 
enterococci in the presence of inducer like 
vancomycin generate precursors with different 
terminals (D-Ala-D-lac, or D-Ala-D-Ser), 
which have low affinity to vancomycin and 
thus can continue in large part to be used to 
synthesize cell wall (Ala denotes alanyl or 
alanine and lactate for VanA, VanB, and 
VanD types of resistance and serine for VanE 
and VanC types) [12, 13]. This shift results in 
a reduced affinity for vancomycin by 1000 and 
seven times respectively [14]. Enterococci are 
traditionally treated with a combination of cell 
wall active antimicrobials such as β-lactams or 
glycopeptides (e.g. ampicillin or vancomycin 
respectively), and aminoglycosides (e.g. 
gentamicin and streptomycin). However, the 
increased rates of β-lactam and glycopeptide 
resistance in E. faecium and aminoglycoside 
resistance in both E. faecium and E. faecalis 
have called for the use of other and perhaps 
less efficient drugs [15]. In conclusion, 
enterococci may be implicated in the transfer 
of vancomycine resistance to different 
veterinary and human pathogens mainly S. 
aureus that represent great hazards in 
treatment failure. 
This work aimed to determine the 
occurrence of Enterococcus species in 
different sources and their antimicrobial 
susceptibilities, as well as the genotypic 
identification of their vancomycin resistant 
genes. This may be used for further 
examination of their conjugative transfer 
abilities within the same and different genus. 
 Material and Methods 
Isolation and identification of enterococci 
Two hundred and twenty-four samples from 
different sources (chickens, turkey, fish, 
humans and food products) were collected. 
Crop and intestinal content of chickens and 
turkey as well as fish intestinal content 
samples were collected and prepared as 
previously described [16]. While the samples 
from liver, ovary, meat or muscles of both 
chickens and turkey were prepared according 
to Peter et al. [17]. Human urine samples from 
outpatient clinic, Zagazig University Hospitals 
were collected and prepared as previously 
mentioned [18]. Finally, raw and mastitis 
cattle milk samples were collected under 
complete aseptic conditions from Sharkia 
Governorate, Egypt as recommended by 
National mastitis council (NMC) [19].  
A loopfull of the prepared samples was 
plated on the surface of the selective media of 
Slanetz and Bartley agar medium as well as 
bile Esculin Agar (BEA) medium and 
incubated at 37˚C for 24 h [20]. Presumptive 
colonies were morphologically identified by 
Gram stain and biochemically examined by 
catalase and sodium chloride tolerance tests 
[20,21]. Their growth at pH 9.6 and 10-45˚C 
was also determined [22,23]. 
Antimicrobial susceptibility testing  
All the Enterococcal isolates were tested for 
their susceptibilities to different antimicrobial 
agents including ampicillin (10 μg), 
cefotaxime (30 μg), erythromycin (15 μg), 
doxycyclin (30 μg), nitrofurnation (300 μg), 
fusdic acid (10 μg), gentamicin (10 and 120 
μg), rifampin (15 μg),) and vancomycin (30 
μg) (Oxoid, Hampshire, England, UK) using 
disc diffusion method [24]. Zone size 
interpretation of antimicrobial agents was 
according to Clinical Laboratory Standards 
Institute (CLSI) M100-S24 [25]. Moreover, 
MIC of vancomycin against the enterococcal 
isolates was carried out by vancomycin agar 
dilution susceptibility test [26], using bile 
esculine azid medium supplemented with 
different concentrations (1024, 512, 256, 128, 
64, 32 and 8 μg/mL) of vancomycin.  
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Table 1: Oligonucleotide primer sequences used in identification of enterococci, virulence and vancomycin 
resistance genes by PCR assays 
PCR product size (bp) Primer sequences (5'-3') Target Specificity 
337 F ATCAGAGGGGGATAACACTT 
R ACTCTCATCCTTGTTCTTCTC 
16Sr RNA Enterococcus 
Genus 
941 F ATCAAGTACAGTTAGTCTTTATTAG 
R ACGATTCAAAGCTAACTGAATCAGT 
16Sr RNA E. faecalis 
658 F TTGAGGCAGACCAGATTGACG 
R TATGACAGCGACTCCGATTCC 
16Sr RNA E. faecium 
288 F TCCTGAATTAGGTGAAAAAAC 
R GCTAGTTTACCGTCTTTAACG 
16Sr RNA E. casseliflavus 
173 F TTACTTGCTGATTTTGATTCG 
R TGAATTCTTCTTTGAAATCAG 
16Sr RNA E. gallinarum 
1,030 F CATGAATAGAATAAAAGTTGCAATA 
R CCCCTTTAACGCTAATACGATCAA 
vanA Vancomycin 
Resistant genes 
433 F GTGACAAACCGGAGGCGAGGA 
R CCGCCATCCTCCTGCAAAAAA 
vanB  
 
Molecular identification  
Polymerase chain reactions were done to 
confirm the conventional methods of isolation 
and identification of genus Enterococcus and 
to detect the Enterococcal species as well as 
vancomycin resistance associated genes (vanA 
and vanB) among the obtained VRE isolates 
using seven pairs of primer sets (Table 1). 
Extraction of DNA from the isolates was 
performed by QIAamp DNA mini Kit 
following the manufacturers’ instructions. 
Cycling conditions of the primer sequences 
during PCR were at primary denaturation of 
94ᵒC/10min and for 35 cycles at (secondary 
denaturation of 94ᵒC/45 sec, annealing of 
50ᵒC/45sec and extension of 72ᵒC/45sec) then 
final extension at 72ᵒC/7min for genes of; 16S 
rRNA of genus Enterococcus [27]; 16S rRNA 
of  E. faecium and E. faecalis; finally vanA 
and vanB [28] while for 30 cycles at (95ᵒC/30 
sec, 55ᵒC/1 min and 72ᵒC/1 min) after primary 
denaturation of 95ᵒC/4 min and then final 
extension at 72ᵒC/7 min for 16srRNA gene of 
E. gallinarum and E. casseliflavus [29] using 
Emerald Amp GT PCR Mastermix (Takara) 
kit. 
Results 
Isolation and identification of enterococci  
Enterococci isolates were recovered with an 
isolation rate of 70%. All the isolates were 
identified by conventional methods. All 
isolates yielded pink colonies on Slantez 
Bartley medium, with a narrow whitish border, 
while on BEA medium, they showed black 
colored colonies. Enterococci appeared as 
Gram positive, none spore forming, non-
capsulated, diplococci or short chains, being 
somewhat elongated, catalase negative, 
tolerated 6.5% NaCl in brain heart infusion 
broth, grew at 9.6 pH and variable degrees of 
temperature (10 – 45˚C). The distribution of 
157 enterococci isolates were 14 (100%) from 
turkey, 85 (78.7%) from chickens, 27 (62.7%) 
from different types of food products, 14 (56 
%) from fish and 17 (50 %) from human urine. 
Antimicrobial susceptibility testing of 
bacterial isolates 
Enterococcal isolates revealed the highest 
susceptibility against vancomycin (84.7%) 
followed by gentamicin 120 (77%), ampicillin 
(73.8%), cefotaxime (63%), nitrofurnation 
(62.4%), doxycycline (35%) and ciprofloxacin 
(29.9%). On the other hand, the resistance 
percentages of the isolates to rifampin was 
85.3%, followed by erythromycin (80.2%), 
cefotaxime (77%), doxycycline (45.8%), 
gentamicin 10 (42%) and ciprofloxacin 
(37.5%). Multidrug resistance (MDR) was 
defined as resistance of bacterial isolates to ≥ 3 
antimicrobial agents and was recorded as 
90.4% in 142 isolates Table (2). 
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Table 2: Antimicrobial susceptibility profile of Enterococcal isolates against 10 antimicrobial agents 
Antibiotics Broilers Turkey Milk Sausage Fish Urine Total 
S I R S I R S I R S I R S I R S I R S I R 
VA 70 9 6 9 5 0 17 1 0 9 0 0 11 3 0 17 0 0 133 18 6 
CN10 22 32 31 2 3 9 10 3 5 4 3 2 0 3 11 6 3 8 44 47 66 
CN120 57 13 15 10 2 2 18 0 0 9 0 0 12 - 2 15 2 0 121 17 19 
AM 67 0 18 12 0 2 5 1 12 9 0 0 14 0 0 9 0 8 116 1 40 
E 0 8 77 0 0 14 0 8 10 3 0 6 - 3 11 0 9 8 3 29 126 
CIP 26 31 28 3 6 5 8 1 9 3 6 0 2 3 9 9 6 2 47 61 59 
F 51 21 13 5 8 1 11 6 1 8 0 1 6 3 5 17 0 0 98 38 21 
DO 27 20 38 3 5 6 8 1 9 9 0 0 5 2 7 3 2 12 55 30 72 
CEF 1 29 55 0 0 14 0 3 15 0 3 6 0 0 14 0 0 17 1 35 121 
RA 5 8 72 0 2 12 0 5 13 3 0 6 0 0 14 0 0 17 8 15 134 
S: sensitive, I: intermediate, R: resistant, VA: Vancomycin, CN120: Gentamicin120, CN10: Gentamicin, AM: Ampicillin, CEF: 
Cefotaxime , F: Fitrofurnation, DO: Doxycycline, CIP: Ciprofloxacin,  , RA: Rifampin, E: Erythromycin. 
 
Moreover, vancomycin agar dilution test 
explored VRE as 84/157 (53.5%) that 
produced a black complex even in the 
presence of vancomycin concentrations such 
as 8, 16, 32, 64, 128, 256 and 512 µg/mL, 
where 59 isolates of them showed intermediate 
resistance to VA at MIC 8 µg/mL [9 isolates 
from   chickens (6) and  milk (3)]; 50 isolates 
[from chickens (21), turkey (3), milk (9), fish 
(3) and human samples (14)] at MIC 16 
µg/mL and 23 isolates at MIC 32 µg/mL 
comprising 21 isolates from chickens and 2 
from turkey. Moreover, 2 isolates from 
chickens expressed high level of resistance at 
MIC 512 µg/mL. Finally, 73 isolates showed 
no growth at all vancomycin concentrations. 
 
Figure 1: Agarose gel electrophoresis of PCR products for Enterococci identification; L: 100 bp Ladder, +ve: 
Positive control, -ve: Negative control, Positive samples show amplicons of specific size (A: 16s rRNA gene 
specific to genus Enterococci producing 337 bp, B: E. faecium-specific 658 bp DNA fragment, C: E. faecalis-
specific 310 bp DNA fragment, D: E. casseliflavus specific 288 bp DNA fragment, E: Amplified 1030 bp 
products of vanA gene, F: Amplified 433 bp products of vanB gene).  
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Molecular identification  
Twenty-eight representative isolates were 
confirmed as enterococci by the amplification 
of 16s rRNA gene with an amplicon size of 
337 bp of (Figure 1 and Table 3). Three 
different Enterococcus spp. of various origins 
were identified. The most prevalent one was E. 
faecalis (42.8%) which was more frequent in 
chicken samples, followed by 11 E. faecium 
(39.2%). Finally, only 3.5% of the examined 
isolates were classified as E. casseliflavus. On 
the other side, E. gallinarum was not detected 
at all and the remaining four isolates were not 
detected at species level (Figure 1 and Table 
3). 
Vancomycin resistance associated genes 
(vanA and vanB) of 28 Enterococcal isolates 
were detected with a high percentage. Out of 
the examined isoates, 22 and 19 harbored 
vanA (78.5%) and vanB (67.8%) genes, 
respectively (Figure 1 and Table 3). The 
mentioned data confirm the high Enterococcal 
distribution and high risk of antibiotic 
resistance (MRD was 85.7%) among most of 
the isolation sources (Table 3). 
 
Table (3): Resistance profile and genotypic characterization of the recovered 28 Enterococcal isolates from 
different sources  
NO Code  
Genotypic 
Identification 
Resistance profile 
M
DR  
VA 
MIC 
µg/mL 
Species vanA vanB    
1 mm3 E.fl + + AM, F,  CIP, CN10,  RA, E. + 
 
16 
2 mm11 E.cassl. + - AM, CEF,  CIP, E. + 16 
3 mm12 E.fm. + + CEF,DO, RA, + 16 
4 mm19 
Other 
E.spp 
+ + CEF, RA, - 
16 
5 ci1 E.fm + + CEF, DO, RA + 16 
6 hu2 E.fl + + AM, CEF, F, DO, CIP,  CN10, E. + 16 
7 hu15 E.fl + + CEF,DO,  CN10, RA, E. + 16 
8 hu43 E.fm + + CEF,  CN10, RA, + 16 
9 hu54 E.fm + + CEF, E. - 16 
10 hu59 E.fm + + CEF, DO, CN10, RA, E. + 16 
11 
ccr2- 
hg- 
E.fm + + VA, CN120, CEF, F, CIP,  CN10, RA, E. + 
512 
12 cr11 E.fm + - CN120, CEF, F, CIP,  CN10, RA, E. + 32 
13 ci23 E.fm + + CN120, AM, CEF, F, CN10, RA, E. + 32 
14 hu16 E.fl + + CEF, DO, CN10, RA, E. + 16 
15 mm26 
Other 
E.spp 
+ + CEF, DO, CN10, RA, E. + 
16 
16 ccr21 E.fm + + VA, CEF, CN10, RA, + 512 
17 ccr10 
Other 
E.spp 
+ + CEF, F, DO, CIP,  CN10, RA, E. + 
32 
        
18 cl1 E.fl + + VA, CN10, E, F and CEF, RA. + 32 
19 ccr6 
Other 
E.spp 
+ + CEF,DO, CIP,  CN10, RA, E. + 
32 
20 ccr12 E.fm + + VA, CEF, DO, CIP,  CN10, RA, E. + 32 
21 ccr9 E.fm + + CEF, F, DO, CIP, CN10, RA, E. + 32 
22 cm6 E.fl + - CN120, CEF, F, DO,  CN10, RA, E. + 32 
23 ci25 E.fl - - CEF, RA - - 
24 ci27 E.fl - - CEF, E. - - 
25 ci31 E.fl - - CEF, RA, E. + - 
26 fi16 E.fl - - CN10, DO , CEF and RA + - 
27 fi38 E.fl - - CN10, E, DO,  CEF and RA + - 
28 co1 E.fl - - CEF, CN10, RA, E. + - 
VA: Vancomycin, CN120: Gentamicin120, CN10: Gentamicin 10, AM: Ampicillin, CEF: Cefotaxime, F: Nitrofurnation, 
DO: Doxycycline, CIP: Ciprofloxacin, RA: Rifampin, E: Erythromycin. E.fl: Enterococcus faecalis. E.fm: Enterococcus 
faecaium. E.cassl.: Enterococcus casseliflavus. Other E.spp.: Enterococcus spp other than E.fl, E.fm, E.cassl. and E. 
gallinarum. mm: mastitis milk, ccr: chicken crop content, ci: chicken intestinal content, cl: chicken liver, co: chicken 
ovary, cm: chicken meat, hu: human urine, fi: fish intestinal content. 
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Discussion 
The obtained results revealed that 
enterococci were widely distributed among the 
samples of human and food product origin 
(broiler, turkey, milk, meat and fish) with a 
high recovery rate (70%). Notably, E. faecalis 
was the predominant species recovered 
(42.8%), followed by E. faecium (39.2%), E. 
casseliflavus (3.5%) and only 4 isolates were 
not identified to species level (14.2%). Similar 
results of E. faecalis predominance but with 
higher percentage (49%) were reported [30]. 
In addition, Gangurde et al. [31] in South West 
part of Slovakia isolated E. faecalis (60%) in 
followed by E. faecium 32.2%. 
Furthermore, Trivedi et al. [32] identified 
five different species of Enterococci including 
E. faecalis followed by E. faecium from 
foodstuffs of different. On contrary, E. 
faecium was the predominant Enterococcus 
species with the percentages of 98.4 % [33], 
61% [34] and 42.9% [35]. Also, Joshua et al. 
[34] identified E. faecalis (29%), E. hirae 
(5.7%), E. casseliflavus (2.1%), E. durans 
(1.2%), E. gallinarum (0.7%), and E. avium 
(0.1%), in meat and only 13 isolates were not 
identified to species level. Herewith, the 
results revealed that Enterococci percentage in 
both meat (sausage) and milk sample are high 
and slightly close to each other as 64.3% and 
62%, respectively. On the contrary, Krocko et 
al. [30] revealed lower levels of contamination 
in meat compared to milk or cheese. 
Milk from different mammalian species 
may contain Enterococci and, therefore, may 
constitute a natural source of such 
microorganisms for consumers. In the present 
study, milk samples from mastitis cow were 
investigated for the presence of enterococci 
and the identified species were E. faecalis, E. 
faecium (the common species), E. 
casseliflavus and only 2 isolates were not 
identified to the species level. Similarly, 
Trivedil et al. [32] reported that E. faecalis and 
E. faecium were the major species identified in 
dairy samples, followed by E. casseliflavus. 
In the current study, all the enterococci 
isolates were tested for their susceptibility to 
different antimicrobial agents from several 
groups by disc diffusion method. The highest 
susceptibility obtained was to vancomycin 
(84.7%) followed by gentamicin120 (77%), 
ampicillin (73.8%), cefotaxime (63%), 
nitrofurnation (62.4%), doxycycline (35%), 
ciprofloxacin (29.9%), gentamicin 10 (28%), 
rifampin (5%) and finally erythromycin 
(1.9%). On the other hand, the resistance 
percentage of isolates to rifampin was (85.3%) 
followed by erythromycin (80.2%). Resistance 
to rifampin seems to be widely spread among 
Enterococci and was the highest percentage 
between the tested antimicrobials (85.3%). 
This was similar to the results of Sarra et al. 
[36], while, Kročko et al. [30] reported that 
tetracycline and gentamicin resistance was the 
most common. Sarra et al.  [36] found that, 
none of the tested isolates demonstrated 
resistance to ampicillin, vancomycin and 
gentamicin. The different data obtained 
previously revealed that none of the strains 
was resistant to vancomycin [32,35]. While, 
Trivedi et al. [32] investigated the microbial 
susceptibility of eight antibiotics using the disk 
diffusion method and indicated lower 
antibiotic resistance for ampicillin and 
gentamicin against 250 Enterococci isolated 
from various food-stuffs.  
Most notably in this study, that the 
resistance of E. faecalis (1/12 and 2/12) and E. 
faecium (2/11 and 1/11) was low against 
vancomycin and ampicillin, respectively. The 
same result was obtained by Sood et al. [35] 
who stated that E. faecalis resistance is low 
against vancomycin and ampicillin but with 
higher levels of ampicillin resistance among E. 
faecium isolates. Erythromycin resistance in 
this work was 80.2%, the same as Sood et al.  
[35] study who proved that erythromycin 
resistance was quite high. Routine 
susceptibility test based on disc diffusion 
method was unreliable for the detection of 
vancomycin resistance upon primary isolation. 
However, the basic method in this study for 
detecting VRE is the incorporation of 
vancomycin into the esculin containing base 
medium (Vancomycin agar dilution test), 
which provides a presumptive identification at 
the genus level because all Enterococci 
hydrolyze esculin. This finding was consistent 
with previously reported studies [18,37].  
The high percentage of VRE was detected 
in this study by Vancomycin agar dilution test 
70 
which revealed that 53.5% (84/157) of the 
isolates grew on BEA medium with variable 
concentrations of vancomycin, of which, 59 
isolates showed intermediate resistance to VA 
at MIC 8-16 µg/mL; 23 isolates at MIC 32 
µg/mL. Moreover, 2 isolates expressed high 
level of resistance at MIC 512 µg/mL and all 
sausage isolates were VSE. On contrary, low 
rate of VRE was proved as 8.4% (MIC ≥32 
mg/ mL) [33] 7.31% [38] and 7% (MIC of 
>512μg/mL) [18]. In another study, 15 isolates 
were found to be VA resistant, of which 4 had 
MIC between 8-16 μg/mL [31].  
Enterococcal antimicrobial resistance is not 
exclusive to the clinical arena but is also 
prevalent in the food industry [14]. The 
absence of VRE from sausage in this work was 
similar to of the findings of Hayes et al. [34] 
in domestic retail meats. In this study, MRD 
(to ≥ 3 antimicrobial) of Enterococcal isolates 
by disc diffusion method was considerably 
high as 90.4% (142/157) and was predominant 
in chicken isolates followed by turkey and 
milk, urine and fish and finally meat isolates 
expressing 48%, 10.5%, 10.5%, 8.6%, 8.6% 
and 3.8%, respectively. While, by vancomycin 
agar dilution test, 24 (85.7%) of 28 
genotypically identified Enterococci had MDR 
as 10 isolates of both E. faecium (90%) and E. 
faecalis (83.3%). As well as 22 (78.6%) of 
them were VRE {11(50%) were E. faecium, 6 
(27.3%) were E. faecalis and others 5 isolates 
were of different spp.}. Similar results were 
previously reported [39,40]. E. faecium was 
the predominant genotype in vancomycin 
resistant isolates but with a higher percentage 
of 83.5% [39]. Lower percentage of MDR was 
identified in pork and chicken samples [30].  
Another study revealed that 61% of E. 
faecium and 11% of E. faecalis isolates 
showed MDR to 17 different antibiotics 
including vancomycin [41]. It is worth noted 
that identification of vancomycin resistance 
via detection of both vanA and vanB genes by 
PCR in the 28 genotypically identified 
Enterococci isolates, proved that 22 were VRE 
isolates in which vanA gene was detected in 
100% (22/22) while vanB gene present in 86.3 
%(19/22) of VRE isolates. Likewise, vanA 
was reported in 100% [38] and 96.5% [39] of 
the examined VRE isolates in previous studies.  
  
Conclusion 
In conclusion, the obtained results indicated 
the spread of VRE isolates which in turn 
highlight the urgent need to limit the 
uncontrolled use of antibiotics in veterinary 
medicine and food animals to avoid drug 
resistance mainly VR and consequently 
treatment failure.  
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 التعريف الظاهري والجيني لميكروب الانتيروكوكاي المقاوم للفانكومايسين في المصادر المختلفة
 عادل عطية محمد1، أحلام عبد العزيز غريب1، ابراهيم محمد اسماعيل 2و أمنية أحمد العوسي3
 الميكروبيولوجي، كلية الطب البيطري، جامعة الزقازيق. قسم 1
 غذية بمعهد بحوث الصحة الحيوانية بالزقازيق.صحة الا قسم 2
 بمعهد بحوث الصحة الحيوانية بالزقازيق. قسم الميكروبيووجي 3
 
مة ضد أهم مضادات الميكروبات المستخدمه فى المجال الاكلينيكى قاوالم لنقل مصدر الانتيروكوكاى المعوية تعتبر المكورات
المقاومة  المعوية المكورات من هذه أنواع انتشار دىم تحديد هدفب سهقد خصصت هذه الدرا لذلكمثل الفانكوميسين . 
 اومه الفانكوميسين الخاصه بهاقم  لجينات لها وكذلك الوراثي التحديد طريق عن ةمختلفصادرم المعزولة من للفانكوميسين و
سماك وبول الانسان وكذلك والرومي الا نة لعزل الانتيروكوكاي من الدجاجعي 422لذلك تم تجميع  )Bnav dna Anav(.
نوعين من الاطعمه مثل اللبن الخام والمصاب بالتهاب الضرع والسجق والتعرف عليها مظهريا عن طريق اختبار تواجد انزيم 
وكذالك النمو في وسط عالى القلويه يحتوي على الاس الهيدروجيني درتها على تحمل تركيز عالى من ملح الطعام قالكتالييز و م
للمضادات البكتيرية المختلفة  تأكيد نمط مقاومة المعزولاتوايضا تم  درجة مئوية 54-01درجات حرارة مختلفة من وفي  6.9
 82كما تم اجراء التعريف الجيني لـ  .الاجار في من الفانكوميسين ةلفختم اتفيفتخ استخدامبو  القرص عبر الانتشارتي بطريق
وكذلك تحديد جينيا عزله من الانتيروكوكاى للكشف عن جنس الانتيروكوكاي وتحديد الصفات الوراثية للانواع المختلفة منها 
تصنيف وقد اسفرت النتائج في هذا البحث عن  تفاعل انزيم البلمرة المتسلسل. تقنيةجينات المقاومة للفانكوميسين بها عن طريق 
حيث تراوح التركيز ). %3.35من المعزولات مظهريا كميكروب الانتيروكوكاي  بنسبة مقاومة عالية للفانكوميسين ( %07
عزلة من عزلات  82ولقد اوضح التحديد الجزيئي لـ ميكروجرام لكل ملي.  215الي  61) من CIMالأدني لمنع نمو البكتريا (
 ةمالمقاو جينات تواجد نسبة اعفارت ايضا اوضحكما ) ، %8.24هي السائدة بنسبة ( silaceaf .Eميكروب الانتيروكوكاي ان 
وعليه تم الإستنتاج الي أن تناول المضادات  فى هذه العزلات.  (٪8.76(Bnav ) و %5.87( Anav  ينميسانكوفلل
كما تعتبر المكورات  .والبشرية ريةالميكروبية خصوصا الفانكوميسين يمكن أن يمثل عامل مؤثر سلبا ًنتيجة الممارسات البيط
 المعوية المقاومة للفانكومايسين حاملا لمقاومة الفانكومايسين. 
 
 
 
